PharVision Advisers’s Dine Brands DIN Stock Holding History

PharVision Advisers’s Portfolio DIN Stock Details DIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,449	Closed	-$345K	–	330
2024 Q4	$345K	Buy	+11,449	New	+$368K	0.29%	113

Other funds holding DIN

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PharVision Advisers's DIN Position: Q1 2025 in Review

PharVision Advisers sold out of Dine Brands (DIN) in Q1 2025, closing a stake of 11,449 shares — an estimated $345K sold.

PharVision Advisers first reported a position in DIN in Q4 2024 and held it in 1 quarter. The position peaked at $345K in Q4 2024. 141 funds tracked by Wall St. Rank hold DIN as of Q1 2025.

PharVision Advisers reported no remaining Dine Brands position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 11,449 Dine Brands shares in Q1 2025, an estimated $345K.
PharVision Advisers first reported a position in Dine Brands in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Dine Brands position peaked at $345K in Q4 2024.
141 funds tracked by Wall St. Rank held Dine Brands as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.